| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |